IP Library Granted Patent US 9,623,199
Granted Patent B2
US 9,623,199 · App. 14/419,457 · Granted Apr 18, 2017

Injection device

Inventors: Frank Richter (Bad Tolz, DE); Ross Macarthur (Frankfurt am Main, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/5086A61M5/20A61M5/3157A61M5/322A61M5/326A61M2205/581A61M2205/582A61M2205/583A61M2205/584
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,623,199
App. No.
14/419,457
Granted
Apr 18, 2017
Kind
B2
Abstract

The invention refers to an injection device comprising a delivery mechanism for injection of a medicament, preferably through a needle, and an end of dose mechanism comprising a feedback element, wherein the end of dose mechanism is operable to be activated at a position at which the delivery mechanism reaches the end of the dose and the end of dose mechanism is further operable to force the feedback element to move into a feedback direction which is opposite or parallel to the activation direction of a release button and/or into the longitudinal direction, wherein the activation direction is preferably a longitudinal direction of the device.

Claims (34)

1. An injection device comprising:

a delivery mechanism for injection of a medicament through a needle, the delivery mechanism comprising a radial element and a lead screw, the lead screw rotatable about a longitudinal axis of the injection device, and the radial element extending radially from the lead screw, and

an end of dose mechanism comprising a feedback element and a radial opening extending radially from the longitudinal axis of the injection device,

wherein the radial element of the delivery mechanism is operable to move along the longitudinal axis of the injection device to pass the radial opening of the end of dose mechanism to activate the end of dose mechanism when the delivery mechanism reaches an end of dose,

wherein the end of dose mechanism is configured to move the feedback element in a feedback direction along the longitudinal axis of the injection device when the end of dose mechanism is activated, the feedback direction being along or opposite to an activation direction of a release button.

2. The injection device according to claim 1 , wherein the feedback element comprises the release button and the feedback direction is opposite to the activation direction.

3. The injection device according to claim 1 , wherein the end of dose mechanism comprises a spring that forces the feedback element to move when the end of dose mechanism is activated.

4. The injection device according to claim 1 , wherein the end of dose mechanism is operable to abruptly force the feedback element into the feedback direction.

5. The injection device according to claim 1 , wherein the lead screw is operable to rotate relative to a nut during the injection of the medicament.

6. The injection device according to claim 1 , wherein the delivery mechanism comprises two engaged elements operable to disengage at the end of dose in order to activate the end of dose mechanism.

7. The injection device according to claim 1 , wherein the end of dose mechanism comprises a ratchet mechanism positioned at an inner surface of the release button to generate an audible signal when the end of dose mechanism is activated.

8. The injection device according to claim 1 , wherein the end of dose mechanism comprises a stop member configured to stop movement of the delivery mechanism when the delivery mechanism reaches the end of dose.

9. The injection device according to claim 1 , wherein the end of dose mechanism generates an audible signal when the end of dose mechanism is activated.

10. The injection device according to claim 1 , wherein the end of dose mechanism generates a visible signal when the end of dose mechanism is activated.

11. The injection device according to claim 1 , wherein the end of dose mechanism is operable to retract the needle when the end of dose mechanism is activated.

12. The injection device of claim 1 , further comprising:

a housing; and

a needle shield movable relative to the housing,

wherein the feedback element comprises the needle shield of the injection device and the feedback direction corresponds to a distal direction along the longitudinal axis of the injection device.

13. The injection device of claim 1 , wherein:

the release button is disposed on a proximal end of a housing of the injection device,

the feedback element comprises the release button,

the activation direction corresponds to a distal direction along the longitudinal axis of the injection device, and

the feedback direction corresponds to a proximal direction along the longitudinal axis of the injection device.

14. The injection device of claim 13 , wherein the end of dose mechanism comprises:

a plate defining the radial opening, and

a spring configured to drive the plate in the proximal direction along the longitudinal axis of the injection device,

wherein, when the end of dose mechanism is activated, the spring drives the plate past the radial element of the delivery mechanism in the proximal direction to move the release button in the proximal direction.

15. The injection device of claim 1 , wherein the delivery mechanism is activated when the release button is moved in the activation direction.

16. The injection device of claim 15 , further comprising a plunger coupled to the delivery mechanism and movable along the longitudinal axis of the injection device, the plunger being configured to inject the medicament through the needle when the delivery mechanism is activated.

17. The injection device of claim 5 , wherein, at the end of dose, the lead screw is rotated such that the radial element extending from the lead screw is aligned with the radial opening of the end of dose mechanism.

18. The injection device of claim 1 , further comprising a cartridge containing a medicament to be delivered when the delivery mechanism is activated.

19. The injection device of claim 1 , wherein the injection device is an autoinjector.

20. The injection device of claim 1 , wherein the radial element is positioned distal to the radial opening of the end of dose mechanism and is operable to pass through the radial opening of the end of dose mechanism such that the radial opening is positioned proximal to the radial opening of the end of dose mechanism when the end of dose mechanism is activated.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2024
From: SANOFI
To: AUTO INJECTION TECHNOLOGIES LLC
Reel/Frame 068553/0306 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2016
From: RICHTER, FRANK; MACARTHUR, ROSS
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 038109/0546 →
Priority Claims (1)
EP 12180357 · Aug 14, 2012 · regional
Continuity (1)
Related Publication 20150190590A1 · Jul 9, 2015